Inhibiting Extracellular Vesicle Trafficking as Antiviral Approach to Corona Virus Disease 2019 Infection

Enrica Urciuoli; Barbara Peruzzi

doi:10.3389/fphar.2020.580505

Inhibiting Extracellular Vesicle Trafficking as Antiviral Approach to Corona Virus Disease 2019 Infection

Enrica Urciuoli, Barbara Peruzzi^*

^*Autore corrispondente per questo lavoro

IRCCS Ospedale pediatrico Bambino Gesù - Roma

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

n/a

Lingua originale	Inglese
pagine (da-a)	N/A-N/A
Rivista	Frontiers in Pharmacology
Volume	11
Numero di pubblicazione	n/a
DOI	https://doi.org/10.3389/fphar.2020.580505
Stato di pubblicazione	Pubblicato - 2020

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

All Science Journal Classification (ASJC) codes

Farmacologia
Farmacologia (medica)

Keywords

Severe Acute Respiratory Syndrome-Associated Coronavirus-2 infection
drug repurposing
exosomes
extracellular vesicles
viruses

Accesso al documento

10.3389/fphar.2020.580505

Altri file e collegamenti

Cita questo

@article{f3c54adb30b04c6e8a07485230b27973,

title = "Inhibiting Extracellular Vesicle Trafficking as Antiviral Approach to Corona Virus Disease 2019 Infection",

abstract = "n/a",

keywords = "Severe Acute Respiratory Syndrome-Associated Coronavirus-2 infection, drug repurposing, exosomes, extracellular vesicles, viruses, Severe Acute Respiratory Syndrome-Associated Coronavirus-2 infection, drug repurposing, exosomes, extracellular vesicles, viruses",

author = "Enrica Urciuoli and Barbara Peruzzi",

year = "2020",

doi = "10.3389/fphar.2020.580505",

language = "English",

volume = "11",

pages = "N/A--N/A",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

publisher = "Frontiers Media SA",

number = "n/a",

}

TY - JOUR

T1 - Inhibiting Extracellular Vesicle Trafficking as Antiviral Approach to Corona Virus Disease 2019 Infection

AU - Urciuoli, Enrica

AU - Peruzzi, Barbara

PY - 2020

Y1 - 2020

N2 - n/a

AB - n/a

KW - Severe Acute Respiratory Syndrome-Associated Coronavirus-2 infection

KW - drug repurposing

KW - exosomes

KW - extracellular vesicles

KW - viruses

KW - Severe Acute Respiratory Syndrome-Associated Coronavirus-2 infection

KW - drug repurposing

KW - exosomes

KW - extracellular vesicles

KW - viruses

UR - https://publicatt.unicatt.it/handle/10807/302906

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85091266920&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85091266920&origin=inward

U2 - 10.3389/fphar.2020.580505

DO - 10.3389/fphar.2020.580505

M3 - Article

SN - 1663-9812

VL - 11

SP - N/A-N/A

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

IS - n/a

ER -

Inhibiting Extracellular Vesicle Trafficking as Antiviral Approach to Corona Virus Disease 2019 Infection

Abstract

OSS delle Nazioni Unite

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo